Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Thorac Oncol. 2019 Jun 12;14(11):1970–1981. doi: 10.1016/j.jtho.2019.05.042

Figure 1. Progression free survival and overall survival according to the presence and type of paraneoplastic syndrome in patients with small cell lung cancer.

Figure 1.

Kaplan-Meier estimates of (A) overall survival and (B) progression free survival in patients with small cell lung cancer according to the absence or presence of a paraneoplastic syndromes. Kaplan-Meier estimates of overall survival (C) and (D) progression free survival limited to only patients who received systemic therapy for small cell lung cancer.